Literature DB >> 19256042

Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents.

Katherine M Coyne, Anton L Pozniak, Mohammed Lamorde, Marta Boffito.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19256042     DOI： 10.1097/qad.0b013e328326ca50

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  16 in total

1.  Advances in the treatment of pulmonary tuberculosis.

Authors:  Xia Zhang; Jing Guo
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

2.  Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.

Authors:  Priti Kambli; Kanchan Ajbani; Chaitali Nikam; Meeta Sadani; Anjali Shetty; Zarir Udwadia; Sophia B Georghiou; Timothy C Rodwell; Antonino Catanzaro; Camilla Rodrigues
Journal:  Int J Mycobacteriol       Date:  2015-10-01

Review 3.  Initiating antiretrovirals during tuberculosis treatment: a drug safety review.

Authors:  Tanuja N Gengiah; Andrew L Gray; Kogieleum Naidoo; Quarraisha Abdool Karim
Journal:  Expert Opin Drug Saf       Date:  2011-01-05       Impact factor: 4.250

Review 4.  Tuberculosis and HIV co-infection: screening and treatment strategies.

Authors:  Kartik K Venkatesh; Soumya Swaminathan; Jason R Andrews; Kenneth H Mayer
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 5.  Safety implications of combined antiretroviral and anti-tuberculosis drugs.

Authors:  Maddalena Cerrone; Margherita Bracchi; Sean Wasserman; Anton Pozniak; Graeme Meintjes; Karen Cohen; Robert J Wilkinson
Journal:  Expert Opin Drug Saf       Date:  2019-12-06       Impact factor: 4.250

6.  THE RISKS OF CONCURRENT TREATMENT WITH TENOFOVIR AND AMINOGLYCOSIDES IN PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS.

Authors:  Chris Kenyon; Nicci Wearne; Rosie Burton; Graeme Meintjes
Journal:  South Afr J HIV Med       Date:  2011       Impact factor: 2.744

Review 7.  Management of individuals requiring antiretroviral therapy and TB treatment.

Authors:  Karen Cohen; Graeme Meintjes
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

8.  Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.

Authors:  Yasuhiro Horita; Norio Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

Review 9.  Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.

Authors:  Aliasgar Esmail; Natasha F Sabur; Ikechi Okpechi; Keertan Dheda
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.